Studsvik (SVIK) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
17 Jul, 2026Executive summary
Q2 2026 sales reached SEK 247 million, growing 9.2% year-over-year, with all business areas contributing.
Adjusted operating profit was SEK 14.3 million (5.8% margin), impacted by one-off costs from the KNXT acquisition and incentive programs.
Acquisition of Kärnfull Next (KNXT) completed, strengthening the new build nuclear market position and project development capabilities.
Strategic investments continued in sales, product, and service development, with expansion in the US and Nordic markets.
Software solutions gained traction in the US, with the first advanced reactors contract and expanded NRC approval.
Financial highlights
Q2 net sales: SEK 247 million (up 9.2% year-over-year); adjusted operating profit: SEK 14.3 million; reported operating profit: SEK 9.2 million, impacted by SEK 5.1 million in one-off costs.
Free cash flow was negative SEK 59.6 million, mainly due to the KNXT acquisition (SEK -34.1 million) and changes in working capital.
Net debt at quarter-end: SEK 138.9 million, up from SEK 118.7 million; equity/assets ratio: 39.1%.
Earnings per share Q2: SEK 0.89; equity per share: SEK 52.02.
Outlook and guidance
Cash flow and working capital management remain key priorities, with continued investments in growth areas and disciplined project execution.
Strategic focus on long-term operations, new build, and advanced nuclear technologies, with ongoing investments in sales, business development, and product innovation.
DRPS margins at 7% are considered sustainable, barring volatility from staffing or project mix.
Ongoing investments in Scandpower and BlackStarTech will continue through 2026 to drive long-term growth.
Latest events from Studsvik
- Strong cash flow and higher profits in 2025, with growth focus and no dividend proposed.SVIK
Q4 20258 Jul 2026 - Sales up 4.1% y/y, profit and cash flow down, SMR acquisition boosts future prospects.SVIK
Q1 202623 Apr 2026 - Q1 2025 saw strong sales, margin gains, and cash flow, driven by nuclear demand and acquisitions.SVIK
Q1 20257 Apr 2026 - Q2 2024 sales and profit rose, with investments and partnerships driving future growth.SVIK
Q2 20243 Feb 2026 - Q3 profit fell sharply on US fraud and technical disruptions despite higher sales.SVIK
Q3 202419 Jan 2026 - Expanding nuclear lifecycle solutions, financial growth, and strategic focus on SMRs and US market.SVIK
ABGSC Investor Days9 Dec 2025 - Q4 sales rose 7.9%, with efficiency gains and acquisitions positioning for 2025 growth.SVIK
Q4 20242 Dec 2025 - Strong Q2 profit and margin growth driven by FMWT and SMR market opportunities.SVIK
Q2 202516 Nov 2025 - Q3 2025 delivered higher profits, strong cash flow, and strategic growth in a robust nuclear market.SVIK
Q3 20254 Nov 2025